Role of oxidatively induced DNA lesions in human pathogenesis. 2010

Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USA. sedelnio@mail.nih.gov

Genome stability is essential for maintaining cellular and organismal homeostasis, but it is subject to many threats. One ubiquitous threat is from a class of compounds known as reactive oxygen species (ROS), which can indiscriminately react with many cellular biomolecules including proteins, lipids, and DNA to produce a variety of oxidative lesions. These DNA oxidation products are a direct risk to genome stability, and of particular importance are oxidative clustered DNA lesions (OCDLs), defined as two or more oxidative lesions present within 10 bp of each other. ROS can be produced by exposure of cells to exogenous environmental agents including ionizing radiation, light, chemicals, and metals. In addition, they are produced by cellular metabolism including mitochondrial ATP generation. However, ROS also serve a variety of critical cellular functions and optimal ROS levels are maintained by multiple cellular antioxidant defenses. Oxidative DNA lesions can be efficiently repaired by base excision repair or nucleotide excision repair. If ROS levels increase beyond the capacity of its antioxidant defenses, the cell's DNA repair capacity can become overwhelmed, leading to the accumulation of oxidative DNA damage products including OCDLs, which are more difficult to repair than individual isolated DNA damage products. Here we focus on the induction and repair of OCDLs and other oxidatively induced DNA lesions. If unrepaired, these lesions can lead to the formation of mutations, DNA DSBs, and chromosome abnormalities. We discuss the roles of these lesions in human pathologies including aging and cancer, and in bystander effects.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D016922 Cellular Senescence Process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS. Aging, Cell,Cell Aging,Cell Senescence,Replicative Senescence,Senescence, Cellular,Senescence, Replicative,Cell Ageing,Cellular Ageing,Cellular Aging,Ageing, Cell,Ageing, Cellular,Aging, Cellular,Senescence, Cell
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D024201 Bystander Effect The result of a positive or negative response (to drugs, for example) in one cell being passed onto other cells via the GAP JUNCTIONS or the intracellular milieu. Bystander Help,Bystander Suppression,Bystander Effects,Effect, Bystander,Effects, Bystander,Help, Bystander,Suppression, Bystander

Related Publications

Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
March 2009, Mutation research,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
May 2010, Free radical biology & medicine,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
January 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
September 2022, DNA repair,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
December 2012, Cancer letters,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
November 2011, DNA repair,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
September 2008, Nucleic acids research,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
January 2021, ACS chemical biology,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
July 2005, Mutation research,
Olga A Sedelnikova, and Christophe E Redon, and Jennifer S Dickey, and Asako J Nakamura, and Alexandros G Georgakilas, and William M Bonner
April 2004, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!